Binh Thai - Thailand

“COVID test kits will need to undergo in-country validation as part of the Class 4 Licensing process in Thailand.”

Binh Thai
General Manager
Asia Actual Thailand

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Thai Requirements for COVID Test Kits

Published on: May 19th, 2021

Similar to other markets in the region, manufacturers of COVID test kits will need to undergo in-country validation as part of the Class 4 Licensing process in Thailand. Like all other medical devices under the new Thai rules, the Thai FDA may take approvals in other countries into account but does not currently have an expedited review route for COVID test products approved in other markets including reference countries. Depending on the type of test, validation fees will vary from 65,000 baht (US$2,200) up to 143,200 baht (US$4,800) and could take 1-4 months to complete. Once validation testing has been completed, manufacturers can then submit their License application through their local office or license holder which incurs a US$1,775)

Validation Requirements

Requirements vary depending on the type of test with sample requirements varying from 100-200 samples. Antigen tests will even require a local clinical trial. Along with lab fees, there will also be a 3,200 baht TFDA application fee applicable to all products.

  • Real Time RT-PCR tests will require 100 samples with lab fees not to exceed 100,000 baht (US$3,000). It is estimated that validation will require 30 working days plus the technology assessment (time required varies).
  • Antibody tests will require 200 samples with lab fees not to 140,000 baht (US$4,600). Validation timeline is currently about 75 days but does depend on the number of products in the queue.
  • Antigen tests will need to work with a local hospital to coordinate a clinical trial before being approved for sale in Thailand. The size, costs, and timelines will depend on the agreement made with the partner hospital plus 30 days for the TFDA’s review.

The TFDA has released a few guidance documents to help manufacturers better understand the process but are currently only available in Thai.

Come Grow With Us

Contact Asia Actual if you’d like to learn more about the regulatory process in Thailand or other markets in the region.

Asia Actual is a regulatory consulting company specializing in helping manufacturers grow their sales through independent license holding, direct fulfillment, and a variety of sales channel support services.

Blog Posts

China’s NMPA Updates Medical Device Classification Catalogue

China’s National Medical Products Administration (NMPA) maintains a list of all medical device categories called the Medical Device Classification Catalogue. NMPA published a notice on August 17, 2023, that they had released amendments to the Medical Device Classification Catalogue. It’s important for manufacturers to understand these changes as they can significantly impact the cost and time to register medical devices.
Read more

Thai FDA Drafting New Guidance for SaMD and AI Device Registration

Thai FDA is drafting new guidelines for AI Regulation. The novel characteristics of artificial intelligence (AI) software cause issues with the medical device registration process in most countries. The Thai Food and Drug Administration (Thai FDA) is working to address this important issue, most recently by hosting a meeting with interested parties on July, 2023, which Asia Actual Thailand employees were invited to attend.
Read more

China NMPA Adds 47 Products to Clinical Trial Exemption List

China’s National Medical Products Administration (NMPA) updated its clinical trial exemption list, adding 47 products. The NMPA updates this list every two to three years, with the last amendment in 2021. This brings the total number of clinical trial exempted product categories in China to 1,025.
Read more